Summarized by Masters of Longevity from Nature - Main.
A yearlong randomized trial found no cognitive benefit from the Spectris AD device.

Key Takeaways
- Trial was negative in 673 people with Alzheimer’s disease.
- Active and sham groups declined by similar amounts.
- Mild subgroup showed smaller effect but remains unproven.



